{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:17:06Z","timestamp":1773937026417,"version":"3.50.1"},"reference-count":20,"publisher":"FapUNIFESP (SciELO)","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"DOI":"10.1590\/1806-9282.20211224","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T14:54:35Z","timestamp":1653490475000},"page":"514-518","source":"Crossref","is-referenced-by-count":4,"title":["Comparison between somatostatin analog injections"],"prefix":"10.1590","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5340-6106","authenticated-orcid":false,"given":"Emre","family":"Gezer","sequence":"first","affiliation":[{"name":"Kocaeli University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3835-9820","authenticated-orcid":false,"given":"Yeliz","family":"Demirhan","sequence":"additional","affiliation":[{"name":"Kocaeli University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0646-8697","authenticated-orcid":false,"given":"Alev","family":"Selek","sequence":"additional","affiliation":[{"name":"Kocaeli University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7114-2565","authenticated-orcid":false,"given":"Zeynep","family":"Cant\u00fcrk","sequence":"additional","affiliation":[{"name":"Kocaeli University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8041-8161","authenticated-orcid":false,"given":"Berrin","family":"\u00c7etinarslan","sequence":"additional","affiliation":[{"name":"Kocaeli University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8428-1115","authenticated-orcid":false,"given":"Mehmet","family":"S\u00f6zen","sequence":"additional","affiliation":[{"name":"Kocaeli University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6349-2976","authenticated-orcid":false,"given":"Damla","family":"K\u00f6ksalan","sequence":"additional","affiliation":[{"name":"Kocaeli University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1723-2038","authenticated-orcid":false,"given":"Ayfer Peker","family":"Karatoprak","sequence":"additional","affiliation":[{"name":"Kocaeli University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2022,4]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1210\/jcem.87.1.8153","article-title":"Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly","volume":"87","author":"Caron P","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(96)90087-6","article-title":"Sandostatin\u00ae LAR\u00ae: a promising therapeutic tool in the management of acromegalic patients","volume":"45","author":"Lancranjan I","year":"1996","journal-title":"Metabolism"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2265.2007.03067.x","article-title":"A 12-month randomized crossover study on the effects of lanreotide Autogel and octreotide long-acting repeatable on GH and IGF-l in patients with acromegaly","volume":"68","author":"Andries M","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1530\/eje.0.1510317","article-title":"Efficacy and tolerability of lanreotide Autogel therapy in acromegalic patients previously treated with octreotide LAR","volume":"151","author":"Alexopoulou O","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11102-011-0335-y","article-title":"Comparison of octreotide LAR and lanreotide autogel as post-operative medical treatment in acromegaly","volume":"15","author":"Tutuncu Y","year":"2012","journal-title":"Pituitary"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2265.1999.00812.x","article-title":"Comparison of six months therapy with octreotide versus lanreotide in acromegalic patients: a retrospective study","volume":"51","author":"Razzore P","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<770::AID-CNCR6>3.0.CO;2-0","article-title":"Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance","volume":"88","author":"O\u2019Toole D","year":"2000","journal-title":"Cancer"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/BF03345632","article-title":"Octreotide-LAR vs lanreotide-SR as first-line therapy for aromegaly: a retrospective, comparative, head-to-head study","volume":"31","author":"Auriemma RS","year":"2008","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/EJE-15-1042","article-title":"Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly","volume":"174","author":"Strasburger CJ","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1517\/14740338.2015.1059817","article-title":"Adverse events associated with somatostatin analogs in acromegaly","volume":"14","author":"Grasso LFS","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"ref11","series-title":"Wong\u2019s essentials of pediatric nursing","author":"Hockenberry MJ","year":"2005","edition":"7th ed."},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1009961116472","article-title":"Efficacy and tolerability of the long-acting somatostatin analog lanreotide in acromegaly. A 12-month multicenter study of 58 acromegalic patients","volume":"2","author":"Chanson P","year":"2000","journal-title":"Pituitary"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin ME","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11102-012-0460-2","article-title":"Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry","volume":"17","author":"Salvatori R","year":"2014","journal-title":"Pituitary"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1530\/eje.0.1430577","article-title":"Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients","volume":"143","author":"Verhelst JA","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s12325-009-0035-4","article-title":"Lanreotide for the treatment of acromegaly","volume":"26","author":"Castinetti F","year":"2009","journal-title":"Adv Ther"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1517\/14740330903379525","article-title":"Octreotide LAR: safety and tolerability issues","volume":"8","author":"Bornschein J","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1185\/03007990903328959","article-title":"From somatostatin to octreotide LAR: evolution of a somatostatin analogue","volume":"25","author":"Anthony L","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00002018-199717050-00004","article-title":"A risk-benefit assessment of octreotide in the treatment of acromegaly","volume":"17","author":"Van der Lely AJ","year":"1997","journal-title":"Drug Saf"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/archinte.1991.00400080073013","article-title":"Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide: results of the international multicenter acromegaly study group","volume":"151","author":"Vance ML","year":"1991","journal-title":"Arch Intern Med"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0104-42302022000400514&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T14:54:54Z","timestamp":1653490494000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302022000400514&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["S0104-42302022000400514"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.20211224","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"value":"1806-9282","type":"electronic"},{"value":"0104-4230","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}